angina

two ways to win two goals target arrow multiple

Biotech

Imbria hits goal in angina trial days after heart failure win

The cardiometabolic biotech reported phase 2 primary endpoint hits for one candidate in two heart disease settings in quick succession.

Nick Paul Taylor Nov 13, 2023 6:10am

Pink Porcelain Anatomical Heart - stock photo Paul CampbellGetty Images

Shockwave Medical offers $100M for angina device maker Neovasc

Jan 17, 2023 12:18pm

heart

Sofinnova, LSP lead $17M round for gene therapy player XyloCor

Dec 6, 2018 10:39am